---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-011930"
form_type: "8-K"
ticker: "ARWR"
cik: "0000879407"
company_name: "ARROWHEAD PHARMACEUTICALS, INC."
filed_at: "2024-03-19T23:59:59+00:00"
generated_at: "2026-06-04T14:21:23.903408+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Arrowhead shareholders elect 7 directors, approve exec pay, ratify KPMG at 2024 annual meeting

## Summary
- All seven director nominees elected; votes for ranged from 76.4M (Given) to 84.3M (Anzalone), with ~19.3M broker non-votes.
- Advisory vote on executive compensation passed with 82.6M for, 4.95M against, 143k abstain.
- Ratification of KPMG as independent auditor for FY2024 passed with 104.1M for, 2.6M against, 366k abstain.
- Record date Jan 19, 2024; 106.99M of 123.84M shares voted at meeting.

## SEC filing metadata
- accession: 0001628280-24-011930
- form_type: 8-K
- ticker: ARWR
- cik: 0000879407
- company_name: ARROWHEAD PHARMACEUTICALS, INC.
- filed_at: 2024-03-19T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/879407/000162828024011930/0001628280-24-011930-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/879407/000162828024011930/arwr-20240314.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-011930
- JSON: https://secwatch.observer/filing/0001628280-24-011930.json
- Plain text: https://secwatch.observer/filing/0001628280-24-011930.txt

## Key facts
- Shareholder Votes
  ARROWHEAD PHARMACEUTICALS, INC. shareholders approved Ratification of KPMG as independent auditors. at the 2024-03-14 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2024-03-14
  source text: Ratification of KPMG as Independent Auditors of the Company 104,057,945 FOR 2,562,563 AGAINST 365,912 ABSTAIN 0 NON VOTES
  evidence_url: https://www.sec.gov/Archives/edgar/data/879407/000162828024011930/0001628280-24-011930-index.htm
- Shareholder Votes
  ARROWHEAD PHARMACEUTICALS, INC. shareholders approved Advisory vote to approve executive compensation. at the 2024-03-14 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2024-03-14
  source text: Advisory Vote to Approve Executive Compensation 82,576,047 FOR 4,950,419 AGAINST 143,385 ABSTAIN 19,316,569 NON VOTES
  evidence_url: https://www.sec.gov/Archives/edgar/data/879407/000162828024011930/0001628280-24-011930-index.htm
- Shareholder Votes
  ARROWHEAD PHARMACEUTICALS, INC. shareholders approved Election of seven directors to serve until next annual meeting. at the 2024-03-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2024-03-14
  source text: Election of Directors NAME FOR AGAINST ABSTAIN NON VOTES Douglass Given 76,397,567 10,968,346 303,938 19,316,569 Michael S. Perry 82,446,900 4,911,855 311,096 19,316,569 Christopher Anzalone 84,313,696 2,976,660 379,495 19,316,569 Mauro Ferrari 81,342,884 6,020,799 306,168 19,316,569 Adeoye Olukoton 83,526,809 3,815,731 327,311 19,316,569 William Waddill 83,279,633 4,079,251 310,967 19,316,569 Victoria Vakiener 83,354,988 3,975,617 339,246 19,316,569
  evidence_url: https://www.sec.gov/Archives/edgar/data/879407/000162828024011930/0001628280-24-011930-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.